Here is how Federal Signal (FSS) and Hitachi Ltd. (HTHIY) have performed compared to their sector so far this year.
Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?
Here is how Editas Medicine (EDIT) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Are Basic Materials Stocks Lagging Centerra Gold (CGAU) This Year?
Here is how Centerra Gold Inc. (CGAU) and New Gold (NGD) have performed compared to their sector so far this year.
Is Abacus Life, Inc. (ABL) Outperforming Other Finance Stocks This Year?
Here is how Abacus Life, Inc. (ABL) and Annaly Capital Management (NLY) have performed compared to their sector so far this year.
Is Fanuc (FANUY) Stock Outpacing Its Industrial Products Peers This Year?
Here is how Fanuc Corp. (FANUY) and Gorman-Rupp (GRC) have performed compared to their sector so far this year.
Are Consumer Discretionary Stocks Lagging Dunelm Group (DNLMY) This Year?
Here is how Dunelm Group (DNLMY) and Madison Square Garden Entertainment (MSGE) have performed compared to their sector so far this year.
Powell Industries (POWL) Crossed Above the 20-Day Moving Average: What That Means for Investors
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround
Sera Prognostics (SERA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Capital Southwest (CSWC) Crossed Above the 20-Day Moving Average: What That Means for Investors
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Cava (CAVA) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for Cava (CAVA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?